Erysipeloid cutaneous leishmaniasis: Treatment with a new, topical, pure herbal extract

European Journal of Dermatology

Volumn 13, Issue 2, 2003, Pages 145-148

  Zerehsaz, Fereidoun ^a   Beheshti, Shohreh ^b   Reza Rezaian, Gholam ^b   Joubeh, Sohaila ^b  

^a Shiraz Multi Specialty Clinic   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Herbal; Leishmaniasis; Medicine

Indexed keywords

ALTHAEA OFFICINALIS EXTRACT; ALTHAEA ROSA EXTRACT; LEGUMINOSA FALIACAEA EXTRACT; LYTHRACAEA EXTRACT; MALVACAEA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG; Z HE;

ACUTE DISEASE; ADULT; AGED; ALTHAEA ROSA; ALTHEA OFFICINALIS; AMASTIGOTE; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; HEALING; HERBAL MEDICINE; HUMAN; LEGUMINOSA FALIACAEA; LYTHRACAEA; MALE; MALVACAEA; MEDICINAL PLANT; PARASITE IDENTIFICATION; RELAPSE; SIDE EFFECT; SKIN LEISHMANIASIS; TOXICITY; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; ERYSIPELOID; FABACEAE; FEMALE; HUMANS; LEISHMANIASIS, CUTANEOUS; LYTHRACEAE; MALE; MALVACEAE; MEDICINE, HERBAL; MIDDLE AGED; PHYTOTHERAPY; PLANT PREPARATIONS; TREATMENT OUTCOME;

EID: 0037358019     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Peters W. "The little sister"- a tale of Arabia [Presidential address: Oct 15, 1987, Manson House]. Trans R Soc Trop Med Hyg 1988; 82: 179-84.
2. Momeni AZ, Aminjavaheri M. Clinical picture of cutaneous leishmoniasis in Isfahan, Iran. Int J Dermatol 1994; 33: 260-5.
3. Salmanpour R, Handjani F, Zerehsoz F, et al. Erysipeloid leishmaniasis: an unusual clinical presentation. Eur J Dermatol 1999; 9: 458-9
4. Anonymous. Drugs for porasitic infections. Med Lett Drugs Ther 1992; 34: 21.
5. Berman JD. Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997; 24: 684-703.
6. Zerehsaz F, Salmanpour R, Handjani F, et al. A double-blind randomized clinical trial of a topical herba extract (Z-HE) versus meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran. Int J Dermotol 1999; 38: 610-2
7. Zerehsaz F, Beheshti Sh, Rezaian GR et al. Amostigote-Positive and Amastigote-Negotive chronic cutaneous leishmaniasis: treatment results with a new topical herbal extract. Irn J Med Sci 2000; 25(3&4): 114-8
8. Zerehsaz F, Beheshti Sh, Rezaian GR, et al. Cutaneous leishmaniasis: what about a new, inexpensive, effective, topical herbal remedy ? J Med Liban 2001; 49: 143-5.
9. Grevelink SA, Lerner EA. Leishmaniasis. J Am Acad Dermatol 1996; 34: 257-72.
10. Killick Kendrick R, Bryceson ADM, Peters W, et al. Zoonotic cutaneous leishmaniasis in Saudi Arabia: lesions healing naturally in man followed by a second infection with the same zygmodeme of Leishmania major. Trans R Soc Trop Med Hyg 1985; 79: 363-5.
11. Herwaldt BL, Berman JD. Recommendations for treating leishmoniasis with sodium stibogluconate(Pentostam®)and review of pertinent clinical studies. Am J Trop Med Hyg 1992; 46: 296-306.
12. Franke ED, Llanos-Cuentas A, Echevarria J, et al. Efficacy of 28-day and 40-day regimens of sodium stibogluconate (Pentostam®) in the treatment of mucosal leishmaniasis. Am J Trop Med Hyg 1994; 51: 77-82.
13. Navin TR, Arana BA, Arana FE, et al. Placebo-controlled clinical trial of sodium stibogluconate(Pentostam®) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 1992; 165: 528-34.
14. Olliaro PL, Bryceson ADM. Practical progress and newdrugs for chaning patterns of leishmaniasis. Parasitology Today 1993; 9: 323-8.
15. Grogl M, Thomason TN, Franke ED. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am J Trop Med Hyg 1992; 47: 117-26.
16. Quellette M, Papdopoulou B. Mechanisms of drug resistance in Leishmania. Parasitology Today 1993; 9: 150-3.
17. WHO Control of the leishmaniasis. Report of a World Health Organization Expert Committee, Technical Report Series 793: 1990.
18. Martinez S, Marr JJ. Allopurinol in the treatment of American cutaneous leishmaniasis. N Eng J Med 1992; 326: 741-4.
19. Velez I, Agudelo S, Hendrickx E, et al. Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A rondomized, controlled trial. Ann Intern Med 1997; 126: 232-6.
20. Sundar S, Rosenkaimer F, Murray HW. Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma. J Infect Dis 1994; 170: 659-62.
21. Farsi RM, Jarallah JS, Khoja TA, et al. Introlesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony. Int J Dermatol 1993; 32: 610-2
22. El-On J, Livshin R, Even-Paz Z, et al. Topical treatment of cutaneous leishmaniasis. J Invest Dermatol 1986; 87: 284-8.
23. Asilian A, Jalayer T, Whitworth JAG, et ol. A randomized, placebo-controlled trial of a two - week regimen of aminosidine (poromomycin) ointment for treatment of cutaneous leishmaniasis in Iran. Am J Trop Med Hyg 1995; 53: 648-51.
24. Ben Salah A, Zakraoui A, Zaatour A, et al. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment. Am J Trop Med Hyg 1995; 53: 162-6.
25. Soto J, Hernandez N, Mejia H, et al. successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimoniate. Clin Infect Dis 1995; 20: 47-51.
26. Raja KM, Khan AA, Hameed A, Rahman SB. Unusual clinical cutaneous leishmaniasis in Pakistan. Br J Dermotol 1998; 139: 111-3.